Lurker Nancy 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Lurker Nancy（CIK 1450485）在 3 家公司共报告 15 笔 SEC Form 4 内部人交易（最近一笔 2026-05-22）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-05-22 | Alkermes plc. (ALKS) | 董事 | 买入 | 6,142 | $0 |
| 2026-05-22 | Alkermes plc. (ALKS) | 董事 | 卖出 | 1,475 | $54,501 |
| 2026-05-18 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | 董事 | 买入 | 8,741 | $0 |
| 2026-05-15 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | 董事 | 卖出 | 4,500 | $161,865 |
| 2026-04-13 | Alkermes plc. (ALKS) | 董事 | 买入 | 3,751 | $0 |
| 2026-04-13 | Alkermes plc. (ALKS) | 董事 | 卖出 | 901 | $30,057 |
| 2026-01-07 | EyePoint, Inc. (EYPT) | 董事 | 买入 | 75,133 | $0 |
| 2026-01-06 | EyePoint, Inc. (EYPT) | 董事 | 买入 | 12,666 | $0 |
| 2025-12-05 | EyePoint Pharmaceuticals, Inc. (EYPT) | 董事 | 卖出 | 9,300 | $140,523 |
| 2025-12-01 | EyePoint Pharmaceuticals, Inc. (EYPT) | 董事 | 卖出 | 200 | $2,990 |
| 2025-12-01 | EyePoint Pharmaceuticals, Inc. (EYPT) | 董事 | 卖出 | 500 | $7,475 |
| 2025-07-11 | EyePoint Pharmaceuticals, Inc. (EYPT) | 董事 | 买入 | 11,111 | $0 |
| 2025-06-02 | Alkermes plc. (ALKS) | 董事 | 买入 | 8,013 | $0 |
| 2025-06-02 | Alkermes plc. (ALKS) | 董事 | 卖出 | 1,924 | $58,894 |
| 2025-05-19 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | 董事 | 买入 | 9,791 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-05-22